3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
29
Lymphoma, Follicular
8
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma
7
Lymphoma, Non-Hodgkin
5
Leukemia, Lymphocytic, Chronic, B-Cell
4
Neoplasms
3
Smoldering Multiple Myeloma
2
Myelodysplastic Syndromes
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Plasma Cell
2
Leukemia, Myelomonocytic, Chronic
2
Burkitt Lymphoma
2
Recurrence
1
Neoplasms, Plasma Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
GATA2 Deficiency
1
Anemia, Refractory, with Excess of Blasts
1
Anemia
1
Interventions
Cyclophosphamide
4
Etoposide
2
sodium-iodide symporter
1
ruxolitinib
1
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
duvelisib
1
cemiplimab
1
X-Rays
1
Whole-Body Irradiation
1
Vincristine
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Prednisone
1
Photons
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunoglobulin G
1
Doxorubicin
1
Disulfides
1
Cyclosporine
1
CTLA-4 Antigen
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
Lenalidomide
×
30 days
×
Clear all
No trials found.